Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
BPC-157 reduces inflammatory cytokine expression in injury models and achieves anti-inflammatory effects at the cellular level without globally suppressing the immune system
Peptides in Perimenopause: A Physician's Cautiously Curious Perspective Written and edited by Sarah Bonza MD, MPH, FAAFP, MSCP, DipABLM, NBC-HWC As a board-certified family physician and Menopause Society Certified Practitioner, I've built my practice on evidence-based medicine
Product Attributes CAS # : 189691-06-3 Molecular Formula : C50H68N14O10 Sequence (AA) : Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH Molecular Weight : 1025.2 g/mol PubChem CID : 9941379 Half-Life : ~2 hours Synonyms : Bremelanotide, PT-141, BMT-141, Vyleesi Type : Synthetic research peptide (melanocortin receptor agonist) Research Focus : Sexual Health & Libido, Neurological & Cognitive Function Scientific References Bremelanotide for treatment of female hypoactive sexual desire Human RCT | Regulatory Efficacy and Safety of Bremelanotide for Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials Human RCT Bremelanotide: an overview of preclinical CNS effects on female sexual function Animal | In vitro The Melanocortin System and Its Role in Sexual Function Animal | In vitro Intranasal bremelanotide in men with erectile dysfunction Human RCT FDA Label: Vyleesi (bremelanotide) injection Regulatory Melanocortin receptor agonists and central regulation of sexual behavior Animal | In vitro Bremelanotide (PT-141): research summary, mechanism, and effects Observational | Human RCT Included In The Box Every product arrives in a premium, custom-designed PEPTIDE.Power box , engineered for convenience, hygiene, and safe storage in your refrigerator
Because the body's own production declines with age, illness, and stress, injection therapy is the most direct way to restore intracellular levels
